Fig. 1. PtdIns(4,5)P2 is enriched at the plasma membrane of resting RPMCs. (A) The monoclonal anti-PtdIns(4,5)P2 antibody 2C11 stains the plasma membrane. RPMCs were fixed and stained at 4°C with (a,b) 2C11 (red) and Draq5TM (blue) or (c) CM-DiI as described in Materials and Methods; (a) shows an equatorial confocal section, (b,c) are projections of confocal sections taken at 1 µm intervals throughout the cell. (B) 2C11 binds PtdIns(4,5)P2 and PtdIns(3,4,5)P3. 2C11 was pre-incubated with 1000-fold molar excess of the indicated inositol phosphate before staining as in (A); equatorial confocal sections are shown. (C) 2C11 specifically detects PtdIns(4,5)P2 on the plasma membrane of RPMCs. Cells were preincubated with 50 µM of the indicated PH domain before staining (b,c), or with 1 mM neomycin during staining with 2C11 (a); equatorial confocal sections are shown. (D) PtdIns(4,5)P2 colocalises with the cortical actin cytoskeleton. Cells were co-stained with 2C11 (red) and Alexa Fluor 488-phalloidin (green) as described in Materials and Methods. A projection of confocal sections taken at 1 µm intervals throughout the cell is shown. (A-C) Micrographs are at the same magnification, except (Ac), which is at the same magnification as (D). Bars, 10 µm.